• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鞘脂类:促炎的 TRAFire 上的油。

Sphingolipids: the oil on the TRAFire that promotes inflammation.

机构信息

Laboratory of Gene Regulation and Signal Transduction, Departments of Pharmacology and Pathology, School of Medicine, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA.

出版信息

Sci Signal. 2010 Sep 28;3(141):pe34. doi: 10.1126/scisignal.3141pe34.

DOI:10.1126/scisignal.3141pe34
PMID:20876871
Abstract

Tumor necrosis factor receptor (TNFR)-associated factors (TRAFs) control inflammatory and immune responses by acting downstream of TNFRs and Toll-like receptors (TLRs). TRAF2 in particular has been extensively studied for its involvement in signaling by TNF-α, the classic inflammatory cytokine. Because it has a RING finger, it has been suggested that TRAF2 acts as an E3 ubiquitin ligase that catalyzes the noncanonical Lys-63 (K63)-linked polyubiquitination of receptor-induced protein 1 (RIP1), which is an essential event in the activation of the IκB kinase complex and consequently nuclear factor κB. Furthermore, TRAF2 itself is subject to K63-linked polyubiquitination, a modification that is rapidly induced upon receptor ligation and was interpreted to be the result of self-ubiquitination. However, formal evidence that TRAF2 is an active E3 ubiquitin ligase was lacking. New evidence shows that sphingosine-1-phosphate (S1P), a sphingolipid that is synthesized during inflammatory responses, is an essential cofactor for TRAF2 ubiquitin ligase activity. S1P binds to TRAF2 and promotes TRAF2-mediated K63-linked RIP1 polyubiquitination, providing direct evidence that TRAF2 is an active E3 ubiquitin ligase and also introducing lipid second messengers into the realm of TNFR and TLR signaling.

摘要

肿瘤坏死因子受体(TNFR)相关因子(TRAFs)通过作用于 TNFR 和 Toll 样受体(TLRs)下游来控制炎症和免疫反应。TRAF2 尤其因其参与 TNF-α(经典炎症细胞因子)信号转导而被广泛研究。由于它具有一个 RING 指结构,因此有人认为 TRAF2 作为一种 E3 泛素连接酶,可催化受体诱导蛋白 1(RIP1)的非典型 Lys-63(K63)连接多泛素化,这是激活 IκB 激酶复合物和随后的核因子 κB 的必要事件。此外,TRAF2 本身也受到 K63 连接多泛素化的修饰,这种修饰在受体结合后迅速诱导,被解释为自身泛素化的结果。然而,缺乏 TRAF2 是一种活性 E3 泛素连接酶的正式证据。新的证据表明,鞘氨醇-1-磷酸(S1P)是一种在炎症反应中合成的鞘脂,是 TRAF2 泛素连接酶活性的必需辅助因子。S1P 与 TRAF2 结合并促进 TRAF2 介导的 K63 连接的 RIP1 多泛素化,这提供了直接证据表明 TRAF2 是一种活性 E3 泛素连接酶,并将脂质第二信使引入 TNFR 和 TLR 信号转导领域。

相似文献

1
Sphingolipids: the oil on the TRAFire that promotes inflammation.鞘脂类:促炎的 TRAFire 上的油。
Sci Signal. 2010 Sep 28;3(141):pe34. doi: 10.1126/scisignal.3141pe34.
2
Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2.鞘氨醇-1-磷酸是 E3 泛素连接酶 TRAF2 的缺失辅因子。
Nature. 2010 Jun 24;465(7301):1084-8. doi: 10.1038/nature09128.
3
Tumor necrosis factor (TNF) receptor-associated factor (TRAF)-interacting protein (TRIP) negatively regulates the TRAF2 ubiquitin-dependent pathway by suppressing the TRAF2-sphingosine 1-phosphate (S1P) interaction.肿瘤坏死因子(TNF)受体相关因子(TRAF)相互作用蛋白(TRIP)通过抑制TRAF2与1-磷酸鞘氨醇(S1P)的相互作用,对TRAF2泛素依赖性途径起负向调节作用。
J Biol Chem. 2015 Apr 10;290(15):9660-73. doi: 10.1074/jbc.M114.609685. Epub 2015 Feb 25.
4
IKKε-mediated tumorigenesis requires K63-linked polyubiquitination by a cIAP1/cIAP2/TRAF2 E3 ubiquitin ligase complex.IKKε 介导的肿瘤发生需要 cIAP1/cIAP2/TRAF2 E3 泛素连接酶复合物通过 K63 链接的多泛素化。
Cell Rep. 2013 Mar 28;3(3):724-33. doi: 10.1016/j.celrep.2013.01.031. Epub 2013 Feb 28.
5
Two coordinated mechanisms underlie tumor necrosis factor alpha-induced immediate and delayed IκB kinase activation.两种协调机制为肿瘤坏死因子-α诱导的即刻和延迟 IκB 激酶激活提供了基础。
Mol Cell Biol. 2013 May;33(10):1901-15. doi: 10.1128/MCB.01416-12. Epub 2013 Mar 4.
6
Direct binding of TRAF2 and TRAF6 to TICAM-1/TRIF adaptor participates in activation of the Toll-like receptor 3/4 pathway.TICAM-1/TRIF 衔接子蛋白与 TRAF2 和 TRAF6 的直接结合参与 Toll 样受体 3/4 通路的激活。
Mol Immunol. 2010 Mar;47(6):1283-91. doi: 10.1016/j.molimm.2009.12.002. Epub 2010 Jan 4.
7
Structural basis for the lack of E2 interaction in the RING domain of TRAF2.肿瘤坏死因子受体相关因子2(TRAF2)的环状结构域中缺乏E2相互作用的结构基础。
Biochemistry. 2009 Nov 10;48(44):10558-67. doi: 10.1021/bi901462e.
8
DR5 suppression induces sphingosine-1-phosphate-dependent TRAF2 polyubiquitination, leading to activation of JNK/AP-1 and promotion of cancer cell invasion.DR5抑制诱导鞘氨醇-1-磷酸依赖性TRAF2多聚泛素化,导致JNK/AP-1激活并促进癌细胞侵袭。
Cell Commun Signal. 2017 May 8;15(1):18. doi: 10.1186/s12964-017-0174-1.
9
TRAF2 regulates TNF and NF-κB signalling to suppress apoptosis and skin inflammation independently of Sphingosine kinase 1.肿瘤坏死因子受体相关因子2(TRAF2)调节肿瘤坏死因子(TNF)和核因子κB(NF-κB)信号通路,以独立于鞘氨醇激酶1的方式抑制细胞凋亡和皮肤炎症。
Elife. 2015 Dec 23;4:e10592. doi: 10.7554/eLife.10592.
10
Targeting signaling factors for degradation, an emerging mechanism for TRAF functions.靶向信号因子进行降解,这是TRAF功能的一种新兴机制。
Immunol Rev. 2015 Jul;266(1):56-71. doi: 10.1111/imr.12311.

引用本文的文献

1
Signaling controversy and future therapeutical perspectives of targeting sphingolipid network in cancer immune editing and resistance to tumor necrosis factor-α immunotherapy.癌症免疫编辑及对肿瘤坏死因子-α免疫疗法耐药中靶向鞘脂网络的信号争议与未来治疗前景
Cell Commun Signal. 2024 May 2;22(1):251. doi: 10.1186/s12964-024-01626-6.
2
Unleashing nature's potential and limitations: Exploring molecular targeted pathways and safe alternatives for the treatment of multiple sclerosis (Review).释放自然的潜力与局限:探索治疗多发性硬化症的分子靶向途径及安全替代方案(综述)
Med Int (Lond). 2023 Aug 17;3(5):42. doi: 10.3892/mi.2023.102. eCollection 2023 Sep-Oct.
3
Phospholipids, the Masters in the Shadows during Healing after Acute Myocardial Infarction.
磷脂:急性心肌梗死后愈合过程中的幕后大师。
Int J Mol Sci. 2023 May 6;24(9):8360. doi: 10.3390/ijms24098360.
4
DR5 suppression induces sphingosine-1-phosphate-dependent TRAF2 polyubiquitination, leading to activation of JNK/AP-1 and promotion of cancer cell invasion.DR5抑制诱导鞘氨醇-1-磷酸依赖性TRAF2多聚泛素化,导致JNK/AP-1激活并促进癌细胞侵袭。
Cell Commun Signal. 2017 May 8;15(1):18. doi: 10.1186/s12964-017-0174-1.
5
NF-κB Pathways in the Pathogenesis of Multiple Sclerosis and the Therapeutic Implications.核因子κB通路在多发性硬化症发病机制中的作用及治疗意义
Front Mol Neurosci. 2016 Sep 15;9:84. doi: 10.3389/fnmol.2016.00084. eCollection 2016.
6
Sphingolipids as new biomarkers for assessment of delayed-type hypersensitivity and response to triptolide.鞘脂类作为评估迟发型超敏反应和雷公藤甲素反应的新型生物标志物。
PLoS One. 2012;7(12):e52454. doi: 10.1371/journal.pone.0052454. Epub 2012 Dec 26.
7
Regulation of the PKCθ-NF-κB Axis in T Lymphocytes by the Tumor Necrosis Factor Receptor Family Member OX40.肿瘤坏死因子受体家族成员 OX40 调控 T 淋巴细胞中的 PKCθ-NF-κB 轴。
Front Immunol. 2012 May 28;3:133. doi: 10.3389/fimmu.2012.00133. eCollection 2012.
8
Hepatic TRAF2 regulates glucose metabolism through enhancing glucagon responses.肝 TRAF2 通过增强胰高血糖素反应来调节葡萄糖代谢。
Diabetes. 2012 Mar;61(3):566-73. doi: 10.2337/db11-0474. Epub 2012 Feb 7.
9
TANK-binding kinase 1 (TBK1) controls cell survival through PAI-2/serpinB2 and transglutaminase 2.TANK 结合激酶 1(TBK1)通过 PAI-2/丝氨酸蛋白酶抑制剂 B2 和转谷氨酰胺酶 2 控制细胞存活。
Proc Natl Acad Sci U S A. 2012 Jan 24;109(4):E177-86. doi: 10.1073/pnas.1119296109. Epub 2011 Dec 27.